China-based preclinical growth slower than expected; CRL
Establishment of complex regulated preclinical studies in China is going to take a lot longer than expected, says CRL, with significant progress taking at least five years.
Archives for February 10, 2011
Minnesota “has raised its game” in pharma manufacturing
Minnesota “has raised its game” in pharma manufacturing and this revival, coupled to drug-device convergence, may justify continuing investment.
PRA opens offices in Israel and Ukraine
Global clinical research organisation (CRO), PRA International, has opened two new offices in Israel and the Ukraine.
AMRI posts Q4 loss on non-cash charges, but sees manufacturing rev gains
Albany Molecular Research Inc. (AMRI) has posted a fourth quarter loss for 2010 after charges relating to a non-cash goodwill and fixed asset impairment of $35.2m.
Appointments at Stabilitech, Unilife, Genocea and Amarin – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Stabilitech, Unilife, Genocea and Amarin.
GSK to move Philly ops to $81m facility
GSK has unveiled plans to move its operations in Philadelphia to a purpose built facility due to be constructed at a former US Navy shipyard.
EDQM developing “live demo” of track & trace anti-counterfeiting tech
The European Directorate for the Quality of Medicines & HealthCare (EQDM) has begun Phase 2 of its “track & track” anti-counterfeiting strategy and is seeking manufacturer participation.